The substance has been found in the drug supplies in eastern regions of the U.S. for years, but this is the first time it has been identified in overdose deaths in San Francisco, according to the San Francisco Department of Public Health.
The department said it is “working to understand the extent of xylazine in the city and respond accordingly.”
The tranquilizer is known to cause severe skin lesions, leaving users open wounds that can lead to infections and even amputations.
“To date in San Francisco there have been no recent reports of increased severity of wounds or syndromes consistent with xylazine intoxication or withdrawal,” the department stated.
While naloxone can restore breathing in an opioid overdose, the user “may still be somnolent or minimally responsive because of the ongoing effects of xylazine, which will gradually wear off,” according to the alert.
“People who are trained in naloxone should be reminded that the goal of an overdose reversal is to restore breathing, not to necessarily restore full consciousness,” the health department states.
Research shows deaths linked to tranq have spread westward across the country, especially in the northeastern states, according to the National Institute of Health. The institute states that from 2015 to 2020, the percentage of all drug overdose deaths involving xylazine jumped from 2 percent to 26 percent in Pennsylvania. Additionally, Xylazine was involved in 19 percent of all drug overdose deaths in Maryland in 2021 and 10 percent in Connecticut in 2020.